Care access and provision for persons surviving opioid overdose and toxic brain injury, with recommendations to address the unfolding polycrisis.  Smart CM, Reaume A, Babaei N, Qualls LK, Schaeffer MJ, Kennedy CJ, Gawryluk JR.  J Subst U…

When trauma triggers craving: meta-analytic evidence for the mediating role of negative affect among trauma-exposed individuals who use substances.  DeGrace S, Smith MM, Ethier-Gagnon MA, Cosman T, Sherry SB, Romero-Sanchiz P, Bird B, Tibbo PG…

Opioid use disorder and dementia risk: evidence from observational and genetic analyses in diverse ancestry cohorts.  Javidnia S, Roe JM, Karhunen V, et al.  Alzheimer's Dement. 2026;22:e71418. doi.org/10.1002/alz.71418  https…

GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and Diabetes.  Pan JY, Elman I, Panchal K, Ramsey KM, Albanese M, Elman DJ, Ramsey DJ.  J Gen Intern Med. 2026 May 18. doi: 10.10…

Fatal Outcome Following Polysubstance Use: A Case Report of Rhabdomyolysis, Acute Kidney Injury, and Deep Vein Thrombosis.  Stoeva-Grigorova S, Yarabanova I, Panayotova I, Radeva-Ilieva M, Bonchev G, Tsekov M, Ivanov D, Milkov M, Marinov S, Ma…

Naldemedine’s Role in Relieving Opioid-Induced Constipation Among Patients on Opioid Agonist Treatment.  Sacco S., Cappa C., Sacco F., Scarzella M., Bartoletti L.:  Heroin Addict Relat Clin Probl. 27, 23, 2025. doi.org/10.62401/2531-4122…